Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 2, 2010, Pages 232-237

  Wang, Chunmei C ^a   Yepes, Luis C ^a   Danaher, Robert J ^a   Berger, Joseph R ^a   Mootoor, Yunanan ^a   Kryscio, Richard J ^a   Miller, Craig S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; FEMALE; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; NONPARAMETRIC TEST; POLYMERASE CHAIN REACTION; SALIVA; VARICELLA ZOSTER VIRUS; VIROLOGY; VIRUS LOAD; VIRUS SHEDDING;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HERPESVIRUS 2, HUMAN; HERPESVIRUS 3, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; POLYMERASE CHAIN REACTION; SALIVA; STATISTICS, NONPARAMETRIC; VIRAL LOAD; VIRUS SHEDDING; YOUNG ADULT;

EID: 74049152972     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.08.037     Document Type: Article

References (49)

1. Greenberg M.S., Glick M., Nghiem L., Stewart J.C., Hodinka R., and Dubin G. Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 (1997) 334-339
2. Hjalmarsson A., Blomqvist P., and Skoldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 45 (2007) 875-880
3. Ward K.N., Andrews N.J., Verity C.M., Miller E., and Ross E.M. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child 90 (2005) 619-623
4. Aurelius E., Forsgren M., Gille E., and Skoldenberg B. Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients. Scand J Infect Dis 34 (2002) 278-283
5. Amstey M.S. Morbidity among adults with varicella-zoster virus infection. Clin Infect Dis 26 (1998) 241-242
6. Kaufman H.E., Azcuy A.M., Varnell E.D., Sloop G.D., Thompson H.W., and Hill J.M. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci 46 (2005) 241-247
7. Niederman J.C. Infectious mononucleosis: observations on transmission. Yale J Biol Med 55 (1982) 259-264
8. Noyola D.E., Valdez-Lopez B.H., Hernandez-Salinas A.E., Santos-Diaz M.A., Noyola-Frias M.A., Reyes-Macias J.F., et al. Cytomegalovirus excretion in children attending day-care centers. Arch Med Res 36 (2005) 590-593
9. Vieira J., Huang M.L., Koelle D.M., and Corey L. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 71 (1997) 7083-7087
10. Mehta S.K., Tyring S.K., Gilden D.H., Cohrs R.J., Leal M.J., Castro V.A., et al. Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis 197 (2008) 654-657
11. Mehta S.K., Cohrs R.J., Forghani B., Zerbe G., Gilden D.H., and Pierson D.L. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 72 (2004) 174-179
12. Miller C.S., Danaher R.J., and Jacob R.J. Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence. Crit Rev Oral Biol Med 9 (1998) 541-562
13. Fons M.P., Flaitz C.M., Moore B., Prabhakar B.S., Nichols C.M., and Albrecht T. Multiple herpesviruses in saliva of HIV-infected individuals. J Am Dent Assoc 125 (1994) 713-719
14. Miller C.S., Avdiushko S.A., Kryscio R.J., Danaher R.J., and Jacob R.J. Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol 43 (2005) 2173-2180
15. Miller C.S., Berger J.R., Mootoor Y., Avdiushko S.A., Zhu H., and Kryscio R.J. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 44 (2006) 2409-2415
16. Druce J., Catton M., Chibo D., Minerds K., Tyssen D., Kostecki R., et al. Utility of a multiplex PCR assay for detecting herpesvirus DNA in clinical samples. J Clin Microbiol 40 (2002) 1728-1732
17. Vrioni G., Kalogeropoulos C., Gartzonika C., Priavali E., and Levidiotou S. Usefulness of herpes consensus PCR methodology to routine diagnostic testing for herpesviruses infections in clinical specimens. Virol J 4 (2007) 59
18. Kim H.N., Meier A., Huang M.L., Kuntz S., Selke S., Celum C., et al. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men. J Infect Dis 194 (2006) 420-427
19. Krone M.R., Wald A., Tabet S.R., Paradise M., Corey L., and Celum C.L. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 30 (2000) 261-267
20. Wald A., Ericsson M., Krantz E., Selke S., and Corey L. Oral shedding of herpes simplex virus type 2. Sex Transm Infect 80 (2004) 272-276
21. Cohrs R.J., Mehta S.K., Schmid D.S., Gilden D.H., and Pierson D.L. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol 80 (2008) 1116-1122
22. Mehta S.K., Crucian B., Pierson D.L., Sams C., and Stowe R.P. Monitoring immune system function and reactivation of latent viruses in the Artificial Gravity Pilot Study. J Gravit Physiol 14 (2007) P21-P25
23. Griffin E., Krantz E., Selke S., Huang M.L., and Wald A. Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive persons. J Med Virol 80 (2008) 1153-1159
24. Lundgren G., Wilczek H., Lönnqvist B., Lindholm A., Wahren B., and Ringdén O. Acyclovir prophylaxis in bone marrow transplant recipients. Scand J Infect Dis Suppl 47 (1985) 137-144
25. Berrey M.M., Schacker T., Collier A.C., Shea T., Brodie S.J., Mayers D., et al. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. J Infect Dis 183 (2001) 1466-1475
26. Chattopadhyay A., Caplan D.J., Slade G.D., Shugars D.C., Tien H.C., and Patton L.L. Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 39-47
27. Cooper D.A. Immunological effects of antiretroviral therapy. Antivir Ther 3 Suppl 4 (1998) 19-23
28. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 694 (1993) 72-77
29. Ryncarz A.J., Goddard J., Wald A., Huang M.L., Roizman B., and Corey L. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol 37 (1999) 1941-1947
30. Pevenstein S.R., Williams R.K., McChesney D., Mont E.K., Smialek J.E., and Straus S.E. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol 73 (1999) 10514-10518
31. Cohrs R.J., Randall J., Smith J., Gilden D.H., Dabrowski C., van Der Keyl H., et al. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol 74 (2000) 11464-11471
32. Volpi A., and Stanberry L. Herpes zoster in immunocompromised patients. Herpes 14 (2007) 31
33. Insinga R.P., Itzler R.F., Pellissier J.M., Saddier P., and Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 20 (2005) 748-753
34. Hung C.C., Hsiao C.F., Wang J.L., Chen M.Y., Hsieh S.M., Sheng W.H., et al. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study. Int J STD AIDS 16 (2005) 673-676
35. Dunic I., Djurkovic-Djakovic O., Vesic S., Zerjav S., and Jevtovic D. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors. Int J STD AIDS 16 (2005) 475-478
36. Gebo K.A., Kalyani R., Moore R.D., and Polydefkis M.J. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr 40 (2005) 169-174
37. Docherty J.J., Trimble J.J., Roman S.R., Faulkner S.C., Naugle F.P., Mundon F.K., et al. Lack of oral HSV-2 in a college student population. J Med Virol 16 (1985) 283-287
38. Kameyama T., Sujaku C., Yamamoto S., Hwang C.B., and Shillitoe E.J. Shedding of herpes simplex virus type 1 into saliva. J Oral Pathol 17 (1988) 478-481
39. Gleeson M., Pyne D.B., Austin J.P., Lynn Francis J., Clancy R.L., McDonald W.A., et al. Epstein-Barr virus reactivation and upper-respiratory illness in elite swimmers. Med Sci Sports Exerc 34 (2002) 411-417
40. Lin S.S., Chou M.Y., Ho C.C., Kao C.T., Tasia C.H., Wang L., et al. Study of the viral infections and cytokines associated with recurrent aphthous ulceration. Microbes Infect 7 (2005) 635-644
41. Schacker T., Ryncarz A.J., Goddard J., Diem K., Shaughnessy M., and Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 280 (1998) 61-66
42. Gutierrez J.P., Conde-Gonzalez C.J., Walker D.M., and Bertozzi S.M. Herpes simplex virus type 2 among Mexican high school adolescents: prevalence and association with community characteristics. Arch Med Res 38 (2007) 774-782
43. Xu F., Sternberg M.R., Kottiri B.J., McQuillan G.M., Lee F.K., Nahmias A.J., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296 (2006) 964-973
44. Da Rosa-Santos O.L., Goncalves Da Silva A., and Pereira Jr. A.C. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey. Int J Dermatol 35 (1996) 794-796
45. Buxbaum S., Geers M., Gross G., Schofer H., Rabenau H.F., and Doerr H.W. Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?. Med Microbiol Immunol 192 (2003) 177-181
46. Looker K.J., Garnett G.P., and Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Org 86 (2008) 805-812
47. Kilgore P.E., Kruszon-Moran D., Seward J.F., Jumaan A., Van Loon F.P., Forghani B., et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 70 Suppl 1 (2003) S111-S118
48. Abu-Raddad L.J., Magaret A.S., Celum C., Wald A., Longini Jr. I.M., Self S.G., et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One 3 (2008) e2230
49. Stamm W.E., Handsfield H.H., Rompalo A.M., Ashley R.L., Roberts P.L., and Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 260 (1988) 1429-1433